147 Importance of right ventricular function in patient referred for cardiac surgery
Matthieu Berry(Clinique des Cèdres), Pascal Lim(Assistance Publique – Hôpitaux de Paris), Pascal Guéret(Hôpitaux Universitaires Henri-Mondor), O. Zaghden(Centre Hospitalier Universitaire Henri-Mondor), Thibaud Damy(Amyloidosis Foundation), Olivier Lairez(Hôpital Rangueil), Alexandre Bensaïd(Inserm), Jean‐Luc Dubois‐Randé(Inserm), Laurent Macron(Clinique Hartmann), Jean-Paul Couëtil(Assistance Publique – Hôpitaux de Paris), Julien Nahum(Inserm)
Cited by 0
Related Papers
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2018|2.8k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2021|1.1k
A new staging system for cardiac transthyretin amyloidosis
|European Heart Journal|2017|740